trabectedin · Apotex · NDA 220837
Evdi
Earliest generic entry, as listed
18 Feb 2043
Blocked by patent: US 12303506.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12303506 | drug product · sets the listed date | 18 Feb 2043 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 220837 · 001 · RLD | solution, intravenous | 1MG/20ML (0.05MG/ML) | 18 Feb 2043 |